Literature DB >> 32516107

Pleural Effusion as a Sign of Coronavirus Disease 2019 (COVID-19) Pneumonia: A Case Report.

Zahra Ahmadinejad1, Faeze Salahshour1, Omid Dadras2, Hesan Rezaei1, SeyedAhmad SeyedAlinaghi3.   

Abstract

BACKGROUND: Recently, COVID-19 infection has become a public health concern. On March 12th, 2020, the World Health Organization (WHO) announced it as a global pandemic. Early diagnosis of atypical cases of COVID-19 infection is critical in reducing the transmission and controlling the present pandemic. In the present report, we described a patient with the chief complaints of dyspnea and dry cough referred to the oncology center at Imam Khomeini Hospital, Tehran, with the differential diagnosis of lung cancer who was diagnosed and treated for COVID-19 infection in follow up. CASE
PRESENTATION: A 59-year-old patient complained of fever, dry cough, and dyspnea from two weeks ago. The patient had been referred to this center with the differential diagnosis of lung cancer due to the massive pleural effusion in the initial chest CT scan. Dyspnea was the patient's main complaint at the time of admission in this center and the oxygen saturation was 84%. In the new chest CT scan, similar findings were observed. Due to the severe respiratory distress, a chest tube was placed in the chest cavity to remove the pleural effusion fluid on day one. The patient's felt relieved immediately after the procedure; however, the oxygen saturation did not rise above 85% despite the oxygen therapy. The cytology of pleural fluid was negative for malignant cells. On day 2, the lymphopenia and high level of CRP suggested the COVID-19 infection. Therefore, a control chest CT scan was conducted and the test for COVID-19 was performed. The CT report indicated the clear pattern of COVID-19's lung involvement in the absence of pleural effusion. Thus, the treatment for COVID-19 was immediately initiated. On day 4, the test reported positive for COVID-19.
CONCLUSION: Currently, it is important to bear in mind the COVID-19 infection in evaluating patients with respiratory symptoms. This report indicated how misleading the presentation of a chest CT scan could be in clinical judgment. Therefore, we recommend ruling out the COVID-19 infection in all the patients with any pattern of lung involvement to avoid missing the potential cases of this vicious infection. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  COVID-19; MERS; lung cancer; pleural effusion; pneumonia

Mesh:

Year:  2021        PMID: 32516107     DOI: 10.2174/1871526520666200609125045

Source DB:  PubMed          Journal:  Infect Disord Drug Targets        ISSN: 1871-5265


  4 in total

Review 1.  Genetic susceptibility of COVID-19: a systematic review of current evidence.

Authors:  SeyedAhmad SeyedAlinaghi; Mohammad Mehrtak; Mehrzad MohsseniPour; Pegah Mirzapour; Alireza Barzegary; Pedram Habibi; Banafsheh Moradmand-Badie; Amir Masoud Afsahi; Amirali Karimi; Mohammad Heydari; Esmaeil Mehraeen; Omid Dadras; Jean-Marc Sabatier; Fabricio Voltarelli
Journal:  Eur J Med Res       Date:  2021-05-20       Impact factor: 2.175

2.  Reduced survival in patients requiring chest tubes with COVID-19 acute respiratory distress syndrome.

Authors:  Nicholas W Rizer; Benjamin Smood; Blake Mergler; Alexandra E Sperry; Christian A Bermudez; Jacob T Gutsche; Asad A Usman
Journal:  JTCVS Open       Date:  2022-04-20

Review 3.  Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID-19): a review of current evidence.

Authors:  Esmaeil Mehraeen; Farzane Behnezhad; Mohammad Amin Salehi; Tayebeh Noori; Hamid Harandi; SeyedAhmad SeyedAlinaghi
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-06-17       Impact factor: 2.503

4.  Pleural effusion in a patient with COVID-19 pneumonia and lung cancer: A case report.

Authors:  Ahmed Muhi Fahad; Hasanain A Al-Khalidi; Yasir Abduljaleel Abdulhameed Alhaideri; Yasir Qays Majeed Altimimi; Ahmed Salih Alshewered
Journal:  Respir Med Case Rep       Date:  2020-11-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.